Trevi Therapeutics, Inc. Balance Sheet
TRVI / Health Care|7 years of annual SEC 10-K data (FY2018-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Trevi Therapeutics, Inc. had $111M in total assets and $100M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34.1M | $32.4M | $12.6M | $36.8M | $45.0M | $57.3M | $7.2M |
| Current Assets | $109.4M | $87.5M | $122.6M | $38.0M | $46.3M | $59.6M | $8.8M |
| PP&E (Net) | $157.0K | $216.0K | $170.0K | $53.0K | $103.0K | $118.0K | $149.0K |
| Total Assets | $110.9M | $89.4M | $123.0M | $38.5M | $47.1M | $60.0M | $10.5M |
| Current Liabilities | $10.5M | $5.8M | $13.4M | $12.7M | $5.6M | $5.2M | $2.7M |
| Shareholders' Equity | $99.6M | $82.5M | $107.5M | $17.1M | $27.3M | $54.5M | -$109.5M |